chr7-150470839-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_175571.4(GIMAP8):āc.647A>Gā(p.Asn216Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000813 in 1,598,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_175571.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GIMAP8 | NM_175571.4 | c.647A>G | p.Asn216Ser | missense_variant | 3/5 | ENST00000307271.4 | |
GIMAP8 | XM_005249950.5 | c.647A>G | p.Asn216Ser | missense_variant | 4/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GIMAP8 | ENST00000307271.4 | c.647A>G | p.Asn216Ser | missense_variant | 3/5 | 1 | NM_175571.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000683 AC: 1AN: 146328Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251262Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135812
GnomAD4 exome AF: 0.00000826 AC: 12AN: 1452348Hom.: 0 Cov.: 29 AF XY: 0.00000830 AC XY: 6AN XY: 723044
GnomAD4 genome AF: 0.00000683 AC: 1AN: 146328Hom.: 0 Cov.: 30 AF XY: 0.0000142 AC XY: 1AN XY: 70630
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.647A>G (p.N216S) alteration is located in exon 3 (coding exon 2) of the GIMAP8 gene. This alteration results from a A to G substitution at nucleotide position 647, causing the asparagine (N) at amino acid position 216 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at